What Does Bristol-Myers Squibb's Debt Look Like?
Portfolio Pulse from Benzinga Insights
Bristol-Myers Squibb Inc. (NYSE:BMY) has seen its shares decrease by 11.11% in the past three months. The company's financial statement as of April 27, 2023, shows a long-term debt of $35.08 billion and current debt of $2.75 billion, amounting to $37.83 billion in total debt. After adjusting for $8.99 billion in cash-equivalents, the company's net debt stands at $28.84 billion. The company's debt-ratio is 0.4, indicating a moderate level of financial leverage.
July 13, 2023 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bristol-Myers Squibb's shares have decreased recently and the company has a significant amount of debt. The debt-ratio of 0.4 indicates a moderate level of financial leverage.
The decrease in Bristol-Myers Squibb's share price and the company's significant debt level could potentially impact investor confidence. The debt-ratio of 0.4, while not excessively high, still indicates a moderate level of financial leverage, which could increase the company's risk in case of interest rate hikes.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100